Presentations 2015
Several presentations were held during Uppsala Health Summit 2015, each centering on a different aspect of how to act on the growing threat of antibiotic resistance. Please find Videos from all plenary sessions here!
Presentations in plenary
Plenary session: Framing the issue
- Dr. Gilles Forte, Global action plan to combat antimicrobial resistance
- Otto Cars, Professor, Uppsala University, Senior Advisor and Founder, ReAct
- Dr. Suwit Wibulpolprasert, Deputy Permanent Secretary and Senior Advisor at the Thai Ministry of Public Health
- John F. Ryan, Acting Director of the European Commission Public Health Directorate
Panel discussion: Gain political commitment and reach implementation
- Dr. Hetty Van Beers-Schreurs, Gain political commitment and reach implementation
- Martha Gyansa-Lutterodt, B.Pharm, MA Health Policy, Director of Pharmaceutical Services, Ghana Ministry of Health
- Dr. Suwit Wibulpolprasert, Deputy Permanent Secretary and Senior Advisor at the Thai Ministry of Public Health
Plenary session: Actions needed
- Dr. Manica Balasegaram, The GAP for AMR: from Action Plan to operations (PDF)
- Professor Ramanan Laxminarayan, Economic Benefits of Antibiotic Growth Promoters in Livestock
- Brendan Barnes, Director IP and Global Health, European Federation of Pharmaceutical Industries
Workshop Presentations
Workshop A: Access not Excess
- Dr Suwit Wibulpolprasert, Deputy Permanent Secretary and Senior Advisor at the Thai Ministry of Public Health, Access vs. Excess to Antimicrobial under the Universal Health Coverage Systems in Thailand
Workshop B: New economic models addressing antibiotic resistance
- Professor John-Arne Røttingen, Division Director, Norwegian Institute of Public Health; Adjunct Professor, Harvard School of Public Health, New Economic Models Addressing Antibiotic Resistance
- Professor Kevin Outterson, Visiting Fellow, Centre for Global Health Security, Royal Institute for International Affairs; Professor, Boston University School of Law and Boston University School of Public Health New Business Models for Antibiotics
Workshop C: The environmental dimension of antibiotic resistance
- Anja Leetz, Executive Director, Healthcare Without Harm, AMR & the environment
Workshop D: Research and innovation for new therapies - collaborative models
- Professor Sarala Balachandran, Professor, Project Director, Open Source Drug Discovery (OSDD); Chief Scientist, Council of Scientific and Industrial Research (CSIR), Open Source Drug Discovery (OSDD) and other collaborative models
- James Andersson, M.Sc., MBA, Head of Corporate Government Affairs, GSK, Collaborative Models for Antibacterial R&D
Workshop E: Improved diagnostics for public health and surveillance
- Dr. Francis Moussy, PhD, Focal Point Diagnostics Innovation, Essential Medicines & Health Products, WHO, Multipurpose Open Point-of-Care Diagnostic Platforms for LMICs
- Dr. Catharina Boehme, Chief Executive Officer, FIND, Switzerland, Improved Diagnostics to fight AMR: Barriers to Development and Uptake (PDF)
Workshop F: Antibiotics in animal production
- Professor Henning Steinfield, Professor, Coordinator Livestock Information, Sector Analysis and Policy Branch (AGAL), Food and Agricultural Organization of the United Nations (FAO); Stanford University, The use of anti-microbials in animal production
- Professor Dick Heederik, Chair of the Expert Committee of the Netherlands Veterinary, Antimicrobial usage in the livestock sector: history, lessons learned and perspectives
Last modified: 2022-05-17